journal article·2024-04-03Open access

Cornea-Specific Human Adipose Stem Cell-Derived Extracellular Matrix for Corneal Stroma Tissue Engineering

Paula Puistola, Abhinav Kethiri, Antti Nurminen, Johannes Turkki, Karoliina Hopia, Susanna Miettinen, Anni Mörö, Heli Skottman

ACS Applied Materials & Interfaces· Volume 16· Issue 13

Abstract

Utilizing tissue-specific extracellular matrices (ECMs) is vital for replicating the composition of native tissues and developing biologically relevant biomaterials. Human- or animal-derived donor tissues and organs are the current gold standard for the source of these ECMs. To overcome the several limitations related to these ECM sources, including the highly limited availability of donor tissues, cell-derived ECM offers an alternative approach for engineering tissue-specific biomaterials, such as bioinks for three-dimensional (3D) bioprinting. 3D bioprinting is a state-of-the-art biofabrication technology that addresses the global need for donor tissues and organs. In fact, there is a vast global demand for human donor corneas that are used for treating corneal blindness, often resulting from damage in the corneal stromal microstructure. Human adipose tissue is one of the most abundant tissues and easy to access, and adipose tissue-derived stem cells (hASCs) are a highly advantageous cell type for tissue engineering. Furthermore, hASCs have already been studied in clinical trials for treating corneal stromal pathologies. In this study, a corneal stroma-specific ECM was engineered without the need for donor corneas by differentiating hASCs toward corneal stromal keratocytes (hASC-CSKs). Furthermore, this ECM was utilized as a component for corneal stroma-specific bioink where hASC-CSKs were printed to produce corneal stroma structures. This cost-effective approach combined with a clinically relevant cell type provides valuable information on developing more sustainable tissue-specific solutions and advances the field of corneal tissue engineering.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Tissue Engineering and Regenerative Medicine · Corneal Surgery and Treatments · Electrospun Nanofibers in Biomedical Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Eye Regeneration Group, Faculty of Medicine and Health Technology, Tampere University, Tampere 33520, Finland

Adult Stem Cell Group, Faculty of Medicine and Health Technology, Tampere University, Tampere 33520, Finland

Tays Research Services, Wellbeing Services County of Pirkanmaa, Tampere University Hospital, 33520 Tampere, Finland

Funding

Silm?- ja kudospankkis??ti? · Academy of Finland · Jane ja Aatos Erkon S??ti? · Business Finland · Suomen Kulttuurirahasto

References (65)

Show source-provided references
1. 10.1016/j.bprint.2018.02.00310.1016/j.bprint.2018.02.003 ↗
2. 10.1016/j.trre.2020.10058510.1016/j.trre.2020.100585 ↗
3. 10.3389/fbioe.2020.60200910.3389/fbioe.2020.602009 ↗
4. 10.1001/jamaophthalmol.2015.477610.1001/jamaophthalmol.2015.4776 ↗
5. 10.1016/j.preteyeres.2015.07.00110.1016/j.preteyeres.2015.07.001 ↗
6. 10.1080/02713683.2019.166387410.1080/02713683.2019.1663874 ↗
7. 10.1016/j.biomaterials.2019.11953610.1016/j.biomaterials.2019.119536 ↗
8. 10.1016/j.exer.2018.05.01010.1016/j.exer.2018.05.010 ↗
9. 10.1002/jbm.a.3670210.1002/jbm.a.36702 ↗
10. 10.1039/C9BM01236B10.1039/C9BM01236B ↗
11. 10.1177/204173141882338210.1177/2041731418823382 ↗
12. 10.1016/j.biomaterials.2018.04.03410.1016/j.biomaterials.2018.04.034 ↗
13. 10.18063/ijb.77410.18063/ijb.774 ↗
14. 10.1111/aos.1461410.1111/aos.14614 ↗
15. 10.1021/acsami.2c0170910.1021/acsami.2c01709 ↗
16. 10.1016/j.exer.2022.10930310.1016/j.exer.2022.109303 ↗
17. 10.1177/2041731422112212310.1177/20417314221122123 ↗
18. 10.1016/j.biomaterials.2014.03.08310.1016/j.biomaterials.2014.03.083 ↗
19. 10.1021/acsami.3c0311710.1021/acsami.3c03117 ↗
20. 10.15283/ijsc.2015.8.2.12110.15283/ijsc.2015.8.2.121 ↗
21. 10.1111/j.1365-2141.2005.05409.x10.1111/j.1365-2141.2005.05409.x ↗
22. 10.3389/fcell.2020.0023610.3389/fcell.2020.00236 ↗
23. 10.1016/j.biotechadv.2018.03.01110.1016/j.biotechadv.2018.03.011 ↗
24. Du Y. · Mol. Vision · 2010 · 16 · 2680
25. 10.1167/tvst.6.1.610.1167/tvst.6.1.6 ↗
26. 10.1016/j.exer.2015.01.02010.1016/j.exer.2015.01.020 ↗
27. 10.1159/00050107110.1159/000501071 ↗
28. 10.1016/j.actbio.2018.07.02210.1016/j.actbio.2018.07.022 ↗
29. 10.1088/1758-5090/acab3410.1088/1758-5090/acab34 ↗
30. 10.3109/1465324090323308110.3109/14653240903233081 ↗
31. QIAamp DNA Mini Kit Quick-Start Protocol, 2018. https://www.qiagen.com/us/products/discovery-and-translational-research/dna-rna-purification/dna-purification/genomic-dna/qiaamp-dna-kits?catno=51304 (accessed June 29, 2023).
32. 10.1016/j.biomaterials.2015.02.00510.1016/j.biomaterials.2015.02.005 ↗
33. Mini-PROTEAN Precast Gels Instruction Manual and Application Guide, 2011. https://www.bio-rad.com/en-fi/sku/4561093-4-20-mini-protean-tgx-precast-protein-gels-10-well-30-ul?ID=4561093 (accessed June 29, 2023).
34. 10.1021/bm400612h10.1021/bm400612h ↗
35. 10.1016/j.biomaterials.2019.11951610.1016/j.biomaterials.2019.119516 ↗
36. 10.1155/2017/690916310.1155/2017/6909163 ↗
37. Cell Proliferation ELISA, BrdU (Colorimetric), 2020. http://www.sigmaaldrich.com/ (accessed June 30, 2023).
38. TISSEEL Package Leaflet: Information for the User, 2020. https://globaladvancedsurgery.baxter.com/tisseel (accessed Nov 06, 2023).
39. Molecular Probes Invitrogen detection technologies. LIVE/DEAD Viability/Cytotoxicity Kit Product Information, 2005. https://www.thermofisher.com/order/catalog/product/L3224 (accessed Aug 30, 2022).
40. 10.1016/j.biopha.2019.10876510.1016/j.biopha.2019.108765 ↗
41. 10.1001/archopthalmol.2011.139810.1001/archopthalmol.2011.1398 ↗
42. 10.1097/ICO.000000000000264610.1097/ICO.0000000000002646 ↗
43. 10.1097/ICO.000000000000122810.1097/ICO.0000000000001228 ↗
44. 10.1186/s40824-023-00348-z10.1186/s40824-023-00348-z ↗
45. 10.1016/j.biomaterials.2011.10.05410.1016/j.biomaterials.2011.10.054 ↗
46. 10.1016/j.bioactmat.2021.09.01410.1016/j.bioactmat.2021.09.014 ↗
47. 10.1038/s41598-021-82678-310.1038/s41598-021-82678-3 ↗
48. 10.2174/15665241280061995010.2174/156652412800619950 ↗
49. 10.1089/scd.2013.047910.1089/scd.2013.0479 ↗
50. 10.1016/j.imlet.2012.06.00110.1016/j.imlet.2012.06.001 ↗
51. 10.3389/fimmu.2014.0055610.3389/fimmu.2014.00556 ↗
52. 10.1002/adhm.20210087210.1002/adhm.202100872 ↗
53. 10.3389/fcell.2020.55835410.3389/fcell.2020.558354 ↗
54. 10.1016/j.exer.2020.10813710.1016/j.exer.2020.108137 ↗
55. 10.1002/jbm.b.3462810.1002/jbm.b.34628 ↗
56. 10.1007/s10439-020-02537-610.1007/s10439-020-02537-6 ↗
57. 10.1634/stemcells.2007-065310.1634/stemcells.2007-0653 ↗
58. 10.1007/s00253-018-8912-x10.1007/s00253-018-8912-x ↗
59. Abraham E. · 2018 · 323
60. 10.3390/cells1116254910.3390/cells11162549 ↗
61. 10.1021/acs.chemrev.0c0008410.1021/acs.chemrev.0c00084 ↗
62. 10.3390/cells1101017810.3390/cells11010178 ↗
63. 10.1080/15384101.2015.112092510.1080/15384101.2015.1120925 ↗
64. 10.1016/j.reth.2015.12.00310.1016/j.reth.2015.12.003 ↗
65. 10.1038/s41598-017-04746-x10.1038/s41598-017-04746-x ↗